4//SEC Filing
Mottola Frank 4
Accession 0001628280-25-008262
CIK 0001356576other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 5:56 PM ET
Size
13.6 KB
Accession
0001628280-25-008262
Insider Transaction Report
Form 4
Mottola Frank
SVP, Quality, GMP, Ops, IT
Transactions
- Exercise/Conversion
Performance Share Units
2025-02-26−2,010→ 0 totalExercise: $0.00→ Common Stock (2,010 underlying) - Exercise/Conversion
Performance Share Units
2025-02-26−3,750→ 0 totalExercise: $0.00→ Common Stock (3,750 underlying) - Exercise/Conversion
Common Stock
2025-02-26+2,010→ 14,909 total - Exercise/Conversion
Common Stock
2025-02-26+3,750→ 17,683 total - Tax Payment
Common Stock
2025-02-26$39.48/sh−976$38,532→ 13,933 total - Tax Payment
Common Stock
2025-02-26$39.48/sh−1,909$75,367→ 15,774 total
Footnotes (3)
- [F1]Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units.
- [F2]On February 22, 2022, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022.
- [F3]On February 23, 2023, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023.
Documents
Issuer
SUPERNUS PHARMACEUTICALS, INC.
CIK 0001356576
Entity typeother
Related Parties
1- filerCIK 0001804567
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 5:56 PM ET
- Size
- 13.6 KB